Researchers are happy but cautious, because this isn’t a strategy for most people with HIV.
Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.
Some Research on Pregnant and Postpartum Women with HIV Is Presented at CROI, But More Trials Are Needed
Pregnant people who are living with or vulnerable to HIV need to be included in clinical trials in order to close our knowledge gaps.
A CROI 2020 roundup of studies on birth control and women living with HIV.
New data shows the drug is not more likely to cause birth defects.
HVTN 702 may not have proven an effective vaccine, but scientists still learned from the research.
Recent Initiation of Testosterone Therapy Linked to Greater Atherosclerosis Progression in MSM With HIV
New findings contribute to the indication that people with HIV taking testosterone therapy should be counseled on the cardiovascular risks.
The biggest may be that more of an HIV-positive person’s equally long lifespan will be spent managing comorbidities, one large study found.
Treating newborns with antiretroviral therapy in the hours after birth may help put HIV into remission.
Although injectable cabotegravir/rilpivirine is still yet to be approved by the FDA, evidence keeps mounting on the effectiveness of the shot for HIV treatment.
COVID-19 will impact both the program content and attendees this year, but there are still important HIV science presentations.